Using an Ordinal Approach to Compare Outcomes Between Vancomycin Versus Ceftaroline or Daptomycin in MRSA Bloodstream Infection

INTRODUCTION: Vancomycin remains first-line therapy for methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections (BSI); however, its toxicity and reported clinical failures are well established. Binary efficacy endpoints evaluating alternative anti-MRSA therapies leave clinicians d...

Descripción completa

Detalles Bibliográficos
Autores principales: Barlow, Ashley, Heil, Emily L., Claeys, Kimberly C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954948/
https://www.ncbi.nlm.nih.gov/pubmed/33484408
http://dx.doi.org/10.1007/s40121-021-00401-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954948/
https://www.ncbi.nlm.nih.gov/pubmed/33484408
http://dx.doi.org/10.1007/s40121-021-00401-1

Ejemplares similares